Stockreport

IN8bio gains after new preclinical data for nsCAR-T cell therapy platform [Seeking Alpha]

IN8bio, Inc.  (INAB) 
PDF proprietary nsCAR platform to selectively eliminate cancer cells while preserving healthy tissue. The data supports the potential for nsCAR to have a wider therapeutic [Read more]